Cascador Health in acquisition of Neuroventis and Galenus Health

Cresco is proud to have acted as legal counsel to Cascador Health, a leading Belgian healthcare technology company, in two significant acquisitions as part of its strategy to enhance its digital health capabilities.

Cascador Health has acquired both Neuroventis, a digital platform specializing in neurology, and Galenus Health, a provider of health data solutions. These strategic acquisitions underscore Cascador Health’s commitment to revolutionizing the healthcare sector by offering advanced medical data solutions to pharmaceutical companies and healthcare providers through personalized medicine initiatives.

Neuroventis brings innovative software designed to improve the management of neurological conditions, while Galenus Health enhances Cascador’s data-driven healthcare offerings. Together, these acquisitions position Cascador Health as a leader in providing comprehensive digital health solutions, advancing the integration of technology and data in patient care.

Many congrats and thanks to Philippe Taillieu and Ludo Ooms for the pleasant collaboration.

Cresco’s deal team, comprising David Dessers, Elske Bleeker, Emma Antonneau and Tim Wirix, provided comprehensive legal guidance throughout the legal due diligence, structuring, negotiation and execution of transaction, ensuring a succesful outcome for all parties involved.

For more details on Cascador Health’s growth strategy, check out the coverage in De Tijd.